Totipotency, pluripotency and nuclear reprogramming

    Research output: Chapter in Book/Report/Conference proceedingChapter

    97 Citations (Scopus)

    Abstract

    Mammalian development commences with the totipotent zygote which is capable of developing into all the specialized cells that make up the adult animal. As development unfolds, cells of the early embryo proliferate and differentiate into the first two lineages, the pluripotent inner cell mass and the trophectoderm. Pluripotent cells can be isolated, adapted and propagated indefinitely in vitro in an undifferentiated state as embryonic stem cells (ESCs). ESCs retain their ability to differentiate into cells representing the three major germ layers: endoderm, mesoderm or ectoderm or any of the 200+ cell types present in the adult body. Since many human diseases result from defects in a single cell type, pluripotent human ESCs represent an unlimited source of any cell or tissue type for replacement therapy thus providing a possible cure for many devastating conditions. Pluripotent cells resembling ESCs can also be derived experimentally by the nuclear reprogramming of somatic cells. Reprogrammed somatic cells may have an even more important role in cell replacement therapies since the patient's own somatic cells can be used for reprogramming thereby eliminating immune based rejection of transplanted cells. In this review, we summarize two major approaches to reprogramming: (1) somatic cell nuclear transfer and (2) direct reprogramming using genetic manipulations.

    Original languageEnglish (US)
    Title of host publicationAdvances in Biochemical Engineering/Biotechnology
    Pages185-199
    Number of pages15
    Volume114
    DOIs
    StatePublished - 2009

    Publication series

    NameAdvances in Biochemical Engineering/Biotechnology
    Volume114
    ISSN (Print)07246145

    Fingerprint

    Stem cells
    Embryonic Stem Cells
    Animals
    Tissue
    Defects
    Cell- and Tissue-Based Therapy
    Cellular Reprogramming
    Germ Layers
    Endoderm
    Ectoderm
    Zygote
    Mesoderm
    Embryonic Structures

    Keywords

    • Embryonic stem cells
    • iPS cells
    • Pluripotent
    • Somatic cell nuclear transfer
    • Totipotent

    ASJC Scopus subject areas

    • Biotechnology
    • Bioengineering
    • Applied Microbiology and Biotechnology

    Cite this

    Mitalipov, S., & Wolf, D. (2009). Totipotency, pluripotency and nuclear reprogramming. In Advances in Biochemical Engineering/Biotechnology (Vol. 114, pp. 185-199). (Advances in Biochemical Engineering/Biotechnology; Vol. 114). https://doi.org/10.1007/10_2008_45

    Totipotency, pluripotency and nuclear reprogramming. / Mitalipov, Shoukhrat; Wolf, Don.

    Advances in Biochemical Engineering/Biotechnology. Vol. 114 2009. p. 185-199 (Advances in Biochemical Engineering/Biotechnology; Vol. 114).

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Mitalipov, S & Wolf, D 2009, Totipotency, pluripotency and nuclear reprogramming. in Advances in Biochemical Engineering/Biotechnology. vol. 114, Advances in Biochemical Engineering/Biotechnology, vol. 114, pp. 185-199. https://doi.org/10.1007/10_2008_45
    Mitalipov S, Wolf D. Totipotency, pluripotency and nuclear reprogramming. In Advances in Biochemical Engineering/Biotechnology. Vol. 114. 2009. p. 185-199. (Advances in Biochemical Engineering/Biotechnology). https://doi.org/10.1007/10_2008_45
    Mitalipov, Shoukhrat ; Wolf, Don. / Totipotency, pluripotency and nuclear reprogramming. Advances in Biochemical Engineering/Biotechnology. Vol. 114 2009. pp. 185-199 (Advances in Biochemical Engineering/Biotechnology).
    @inbook{a5cb6a1b76994f49800a908b61f6a6f8,
    title = "Totipotency, pluripotency and nuclear reprogramming",
    abstract = "Mammalian development commences with the totipotent zygote which is capable of developing into all the specialized cells that make up the adult animal. As development unfolds, cells of the early embryo proliferate and differentiate into the first two lineages, the pluripotent inner cell mass and the trophectoderm. Pluripotent cells can be isolated, adapted and propagated indefinitely in vitro in an undifferentiated state as embryonic stem cells (ESCs). ESCs retain their ability to differentiate into cells representing the three major germ layers: endoderm, mesoderm or ectoderm or any of the 200+ cell types present in the adult body. Since many human diseases result from defects in a single cell type, pluripotent human ESCs represent an unlimited source of any cell or tissue type for replacement therapy thus providing a possible cure for many devastating conditions. Pluripotent cells resembling ESCs can also be derived experimentally by the nuclear reprogramming of somatic cells. Reprogrammed somatic cells may have an even more important role in cell replacement therapies since the patient's own somatic cells can be used for reprogramming thereby eliminating immune based rejection of transplanted cells. In this review, we summarize two major approaches to reprogramming: (1) somatic cell nuclear transfer and (2) direct reprogramming using genetic manipulations.",
    keywords = "Embryonic stem cells, iPS cells, Pluripotent, Somatic cell nuclear transfer, Totipotent",
    author = "Shoukhrat Mitalipov and Don Wolf",
    year = "2009",
    doi = "10.1007/10_2008_45",
    language = "English (US)",
    isbn = "9783540888055",
    volume = "114",
    series = "Advances in Biochemical Engineering/Biotechnology",
    pages = "185--199",
    booktitle = "Advances in Biochemical Engineering/Biotechnology",

    }

    TY - CHAP

    T1 - Totipotency, pluripotency and nuclear reprogramming

    AU - Mitalipov, Shoukhrat

    AU - Wolf, Don

    PY - 2009

    Y1 - 2009

    N2 - Mammalian development commences with the totipotent zygote which is capable of developing into all the specialized cells that make up the adult animal. As development unfolds, cells of the early embryo proliferate and differentiate into the first two lineages, the pluripotent inner cell mass and the trophectoderm. Pluripotent cells can be isolated, adapted and propagated indefinitely in vitro in an undifferentiated state as embryonic stem cells (ESCs). ESCs retain their ability to differentiate into cells representing the three major germ layers: endoderm, mesoderm or ectoderm or any of the 200+ cell types present in the adult body. Since many human diseases result from defects in a single cell type, pluripotent human ESCs represent an unlimited source of any cell or tissue type for replacement therapy thus providing a possible cure for many devastating conditions. Pluripotent cells resembling ESCs can also be derived experimentally by the nuclear reprogramming of somatic cells. Reprogrammed somatic cells may have an even more important role in cell replacement therapies since the patient's own somatic cells can be used for reprogramming thereby eliminating immune based rejection of transplanted cells. In this review, we summarize two major approaches to reprogramming: (1) somatic cell nuclear transfer and (2) direct reprogramming using genetic manipulations.

    AB - Mammalian development commences with the totipotent zygote which is capable of developing into all the specialized cells that make up the adult animal. As development unfolds, cells of the early embryo proliferate and differentiate into the first two lineages, the pluripotent inner cell mass and the trophectoderm. Pluripotent cells can be isolated, adapted and propagated indefinitely in vitro in an undifferentiated state as embryonic stem cells (ESCs). ESCs retain their ability to differentiate into cells representing the three major germ layers: endoderm, mesoderm or ectoderm or any of the 200+ cell types present in the adult body. Since many human diseases result from defects in a single cell type, pluripotent human ESCs represent an unlimited source of any cell or tissue type for replacement therapy thus providing a possible cure for many devastating conditions. Pluripotent cells resembling ESCs can also be derived experimentally by the nuclear reprogramming of somatic cells. Reprogrammed somatic cells may have an even more important role in cell replacement therapies since the patient's own somatic cells can be used for reprogramming thereby eliminating immune based rejection of transplanted cells. In this review, we summarize two major approaches to reprogramming: (1) somatic cell nuclear transfer and (2) direct reprogramming using genetic manipulations.

    KW - Embryonic stem cells

    KW - iPS cells

    KW - Pluripotent

    KW - Somatic cell nuclear transfer

    KW - Totipotent

    UR - http://www.scopus.com/inward/record.url?scp=77950800100&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=77950800100&partnerID=8YFLogxK

    U2 - 10.1007/10_2008_45

    DO - 10.1007/10_2008_45

    M3 - Chapter

    SN - 9783540888055

    VL - 114

    T3 - Advances in Biochemical Engineering/Biotechnology

    SP - 185

    EP - 199

    BT - Advances in Biochemical Engineering/Biotechnology

    ER -